Showing results (771-780 of 1,609) with videos related to
Sort By:
Pageof 161
JAMA Oncology|June 18, 2026
Second Primary Malignant Neoplasms After T-Cell-Engaging Bispecific Antibody Therapy: A Systematic Review and Meta-AnalysisJaromir Tomasik, Tobias Tix, Mohammad Alhomoud, et al.JAMA Oncology|June 18, 2026
Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Nonrandomized Clinical TrialThomas Zilli, Ciro Franzese, Matthias Guckenberger, et al.JAMA Oncology|July 9, 2026
Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical TrialDo-Youn Oh, Aiwu Ruth He, Shukui Qin, et al.JAMA Oncology|June 25, 2026
Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe TrialPaolo Tarantino, Tianyu Li, Esther Ritah Ogayo, et al.JAMA Oncology|July 2, 2026
Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in CirrhosisAbderrahim Oussalah, Maël Silva Rodriguez, Guillaume Conroy, et al.JAMA Oncology|August 6, 2026
Mathematical Biomarkers of Adaptive Therapy Outcomes in Prostate CancerKit Gallagher, Maximilian A Strobl, Robert A Gatenby, et al.JAMA Oncology|August 6, 2026
Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer: A Randomized Clinical TrialMaria M Karsten, Pimrapat Gebert, Therese Pross, et al.JAMA Oncology|July 23, 2026
Ultralow-Dose Interleukin 10-Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Nonrandomized Clinical TrialYongxian Hu, Mingming Zhang, Min Gao, et al.JAMA Oncology|August 27, 2026
Cancer Biologics Utilization After Biosimilar Entry and Financial Implications For Payers and PatientsXiaoyu Liu, Xiaoyi Xu, Z John Lu, et al.JAMA Oncology|August 27, 2026
Systemic Therapy Considerations in Older Adults With Early-Stage Breast Cancer: A ReviewClaire E Smith, Sarah L Sammons, Christina A Minami, et al.Pageof 161